322
Participants
Start Date
May 5, 2024
Primary Completion Date
May 5, 2027
Study Completion Date
October 31, 2027
Support platform
"The study will be conducted over a 12-month period. This should allow participants to see their medical team 2 to 3 times during this timeframe. Participants of arms 1 and 2 will have access to the Support platform and will receive a monthly newsletter, informing them of news on the platform and acting as a reminder to log in. Several features are included in this responsive-designed platform to enhance participation, such as a visual of personal progress, ability to bookmark content, change their avatar.~Support contains 3 main components: Educational material, News blog written by HCPs weekly in collaboration with patient-partners on up-to-date topics related to T1D, a peer-to-peer discussion forum which is moderated daily by a HCP specializing in T1D."
RECRUITING
Institut de recherches cliniques de Montréal, Montreal
RECRUITING
Centre hospitalier de l'université de Montreal, Montreal
RECRUITING
Centre hospitalier de Quebec, Université Laval, Québec
RECRUITING
Centre de médecine métabolique de Lanaudière, Terrebonne
Institut de Recherches Cliniques de Montreal
OTHER
Centre Hospitalier de l'Universite Laval (CHUL)
UNKNOWN
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER
Centre de médecine métabolique de Lanaudière
UNKNOWN
McGill University
OTHER